Prescriber Safety Initiative
  • Home
  • About
  • News
  • Resources
  • Events
  • FAQ & Support
  • Programs
    • Laws and Regulations Governing Buprenorphine for OUD
    • Managing the Legal Risks of Prescribing Controlled Medications
    • Preparing for and Responding to DEA Visits
    • Prescribing Buprenorphine for OUD During a Public Health Emergency
  • Home
  • About
  • News
  • Resources
  • Events
  • FAQ & Support
  • Programs
    • Laws and Regulations Governing Buprenorphine for OUD
    • Managing the Legal Risks of Prescribing Controlled Medications
    • Preparing for and Responding to DEA Visits
    • Prescribing Buprenorphine for OUD During a Public Health Emergency
All Posts By

Theo

DEA Extends Telemedicine Flexibilities for Prescribing Controlled Substances

DEA Extends Telemedicine Flexibilities for Prescribing Controlled Substances

October 24, 2023
DEA Releases 2024 National Drug Threat Assessment

DEA Releases 2024 National Drug Threat Assessment

July 21, 2023
Print this page

© 2024 Center for U.S. Policy. All Rights Reserved.